Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eolo in NERD
NCT07041060Completed
- Sponsor
- Alma Mater Studiorum – Università di Bologna
- Start
- May 2025
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Randomised trial (3 arms), sponsored by Alma Mater Studiorum – Università di Bologna. Primary endpoint: Gastroesophageal Reflux Disease-Health Related Quality of Life at 24 weeks. Started May 2025; status: completed.
Beyond the preview
Go deeper on NCT07041060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07041060.